These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 12197198)

  • 1. Toxicological screening for drugs of abuse in samples adulterated with household chemicals.
    Uebel RA; Wium CA
    S Afr Med J; 2002 Jul; 92(7):547-9. PubMed ID: 12197198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methaqualone (Mandrax) abuse, urine testing, and identification: clinical correlation between a new mass urinalysis test and a military drug abuse program.
    Rock NL; Moore RJ
    Int J Addict; 1976; 11(2):237-44. PubMed ID: 1262091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adulterants in Urine Drug Testing.
    Fu S
    Adv Clin Chem; 2016; 76():123-63. PubMed ID: 27645818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Performance of three point-of-care urinalysis test devices for drugs of abuse and therapeutic drugs applied in the emergency department.
    Attema-de Jonge ME; Peeters SY; Franssen EJ
    J Emerg Med; 2012 Jun; 42(6):682-91. PubMed ID: 21911284
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid urine drug screens: diphenhydramine and methadone cross-reactivity.
    Rogers SC; Pruitt CW; Crouch DJ; Caravati EM
    Pediatr Emerg Care; 2010 Sep; 26(9):665-6. PubMed ID: 20838187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel spot tests for detecting the presence of zinc sulfate in urine, a newly introduced urinary adulterant to invalidate drugs of abuse testing.
    Welsh KJ; Dierksen JE; Actor JK; Dasgupta A
    Am J Clin Pathol; 2013 Oct; 140(4):572-8. PubMed ID: 24045556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cannabis and other drug use among trauma patients in three South African cities, 1999-2001.
    Parry CD; Plüddemann A; Donson H; Sukhai A; Marais S; Lombard C
    S Afr Med J; 2005 Jun; 95(6):429-32. PubMed ID: 16100892
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance evaluation of three on-site adulterant detection devices for urine specimens.
    Peace MR; Tarnai LD
    J Anal Toxicol; 2002 Oct; 26(7):464-70. PubMed ID: 12423001
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urine adulterant test for oxidants yields positive results from microbial-contaminated urine.
    Brazwell E; Crossey M; Racz M; Quitoriano T; Chavez M
    J Anal Toxicol; 2004; 28(8):692-3. PubMed ID: 15586447
    [No Abstract]   [Full Text] [Related]  

  • 10. The South African Community Epidemiology Network on Drug Use (SACENDU) project, phases 1-8--cannabis and Mandrax.
    Bhana A; Parry CD; Myers B; Plüddemann A; Morojele NK; Flisher AJ
    S Afr Med J; 2002 Jul; 92(7):542-7. PubMed ID: 12197197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A procedure for the detection of Stealth adulterant in urine samples.
    Valtier S; Cody JT
    Clin Lab Sci; 2002; 15(2):111-5. PubMed ID: 12776774
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical issues associated with urine testing of substances of abuse.
    Eskridge KD; Guthrie SK
    Pharmacotherapy; 1997; 17(3):497-510. PubMed ID: 9165553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protocol for accuracy of point of care (POC) or in-office urine drug testing (immunoassay) in chronic pain patients: a prospective analysis of immunoassay and liquid chromatography tandem mass spectometry (LC/MS/MS).
    Manchikanti L; Malla Y; Wargo BW; Cash KA; Pampati V; Damron KS; McManus CD; Brandon DE
    Pain Physician; 2010; 13(1):E1-E22. PubMed ID: 20119473
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Simultaneous identification and quantitation of diphenhydramine and methaqualone.
    Hindmarsh KW; Hamon NW; LeGatt DF
    Clin Toxicol; 1977 Sep; 11(2):245-55. PubMed ID: 891115
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of urine adulterants on commercial drug abuse screening test strip results.
    Rajšić I; Javorac D; Tatović S; Repić A; Đukić-Ćosić D; Đorđević S; Lukić V; Bulat Z
    Arh Hig Rada Toksikol; 2020 Mar; 71(1):87-93. PubMed ID: 32597134
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a urine on-site drugs of abuse screening test in patients admitted to a psychiatric emergency unit.
    Bagøien G; Morken G; Zahlsen K; Aamo T; Spigset O
    J Clin Psychopharmacol; 2009 Jun; 29(3):248-54. PubMed ID: 19440078
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deterrence of methaqualone abuse through mass urinalysis.
    Jeffer EK
    Int J Addict; 1979 Apr; 14(3):445-50. PubMed ID: 468434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent substance intake among patients admitted to acute psychiatric wards: physician's assessment and on-site urine testing compared with comprehensive laboratory analyses.
    Mordal J; Holm B; Mørland J; Bramness JG
    J Clin Psychopharmacol; 2010 Aug; 30(4):455-9. PubMed ID: 20631563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Screening for urinary amphetamine in truck drivers and drug addicts.
    Pidetcha P; Congpuong P; Putriprawan T; Rekakanakul R; Suwanton L; Tantrarongroj S
    J Med Assoc Thai; 1995 Oct; 78(10):554-8. PubMed ID: 8576663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [False positive screening for drugs of abuse].
    Watine J
    Ann Biol Clin (Paris); 2003; 61(3):367-8. PubMed ID: 12825552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.